Description
SC-2TRZ is a novel synthetic dual-action peptide designed for advanced metabolic research that activates GLP-1 and GIP receptors concurrently, enabling integrated investigation of metabolic pathways. It is a gastric inhibitory polypeptide analog and a GLP-1 receptor agonist. It is provided to allow investigations involved in weight regulation, glucose metabolism, and energy balance, it provides researchers with a powerful tool to study comprehensive metabolic responses.





